Kowalski, Dariusz M.

• Vol 10, No 1 (2014) - EXPERTS' OPINION
  The role of systemic therapies of non-small cell lung cancer and malignant pleural mesothelioma: updated expert recommendations
  Abstract  PDF (Polish)
• Vol 11 (2015): Wydanie specjalne - SPECIAL ISSUE
  Leczenie wspomagające w onkologii — zmiany 1995–2015
  Details
• Vol 18, No 2 (2022) - REVIEW ARTICLES
  Immune checkpoint inhibitors in the first-line treatment of metastatic small-cell lung cancer
  Abstract  PDF  HTML
• Vol 19, No 2 (2023) - EXPERTS' OPINION
  Common statement of experts of the Polish Oncological Society, Polish Lung Cancer Group, Polish Society of Lung Diseases, Polish Society of Gastroenterology, Polish Society of Endocrinology, and the Polish Society of Cardiology for minimal requirements in diagnosis and monitoring of selected adverse events of immunotherapy in oncological patients
  Details  PDF  HTML
• Vol 19, No 4 (2023) - EXPERTS' OPINION
  Expert opinion on adjuvant treatment with osimertinib in patients with non-small cell lung carcinoma after radical tumor resection
  Details  PDF  HTML
• Ahead of print - REVIEW ARTICLES
  Pembrolizumab in combination with chemotherapy in patients with advanced squamous cell lung cancer — clinical trials and real-world data
  Abstract  PDF